mills21/iStock/Thinkstock
First CAR-T therapy to target BCMA gets FDA nod
The US Food and Drug Administration (FDA) has approved a chimeric antigen receptor (CAR)-T cell immunotherapy for the treatment of multiple myeloma. The first-in-class BCMA-directed CAR-T therapy received the agency’s go-ahead on 26 March.
Nature Biotechnology
US backs waiving patents on COVID vaccines
In a historic move, the US government has announced that it supports waiving patent protections for COVID-19 vaccines, a measure aimed at boosting supplies so that people around the world can get the shots.
Nature
Mix-and-match COVID vaccines trigger potent immune response
Preliminary results from a trial of more than 600 people are the first to show the benefits of combining different vaccines.
Nature
China’s COVID vaccines are going global—but questions remain
The WHO has approved one of China’s COVID-19 vaccines for use worldwide and another is under review. But published trial data remain scarce.
Nature
Podcast
Business of science: tips and tricks for a perfect investor pitch
Seasoned science entrepreneurs tell Adam Levy how to take the daunting first steps to commercializing your research.
Nature Careers
Business of science: How to register a patent
Scientist-turned-lawyer Tamsen Valoir outlines a key step on the road to commercializing your research.
Nature Careers
